A new option in the treatment of AMD
Date: 17/03/2020
Venue: Bundaberg Eye Clinic, 302 Bourbong St, Bundaberg , QLD, 4670
Provider: Inservio- change it as required
Contact: Justine Cant, [E] justine.cant@inservio.com.au, [P] 0425600318
Learning Objectives
- Participants will receive an introduction to Beovu
- Participants will understand the molecular structure of Beovu
- Participants will understand the different molecular structures of all current PBS listed treatments for AMD
- Participants will understand the Beovu Hawk and Harrier trial data
- Particiapants will be aware of the TGA indication of Beovu
- Participants will discuss AMD cases based on presentation of OCT and OCTA
- Participants will understand the use of OCTA in the diagnosis of AMD
- Particiapants will understand the use of using OCTA in diagnosing preclinical exudative macular degenetation
Max points awarded: 3.34
Session Information
| Name |
|---|
| Introdction to Beovu |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.67 |
| Name |
|---|
| Beovu as a new option in the treatment of AMD |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| Case Presentations |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.67 |
| Name |
|---|
| Use of OCTA in diagnosis of AMD |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |